Keyphrases
Myelodysplastic Syndrome
100%
Allogeneic Transplantation
100%
Conditioning Intensity
100%
Myeloablative Conditioning
50%
Overall Survival
50%
Relapse-free Survival
50%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
33%
Relapse Risk
33%
Reduced-intensity Conditioning
33%
Random Assignment
33%
Relapse Rate
33%
Transplant-related Mortality
33%
Myeloblasts
33%
DNA Sequencing
16%
Leukemia
16%
Adult Patients
16%
Clinical Trials Network
16%
Marrow
16%
Clinical Endpoints
16%
Genomic Testing
16%
Blood Samples
16%
Post-transplant Relapse
16%
Transplantation Conditioning
16%
Gene-rich Regions
16%
Ultra-deep Well
16%
Marrow Transplantation
16%
Relapse-free
16%
Targeted Sequencing
16%
Morphological Analysis
16%
Pretransplant Assessment
16%
Randomized Phase III Trial
16%
Immunology and Microbiology
Conditioning
100%
Allograft
100%
Overall Survival
37%
Recurrence Free Survival
37%
Cell Transplantation
25%
DNA Sequence
25%
Myeloblast
25%
Hematopoietic Cell
25%
Arm
12%
Morphology
12%